|
[未来]
结直肠癌肝转移:未来方向
日期:2022-03-03 09:03:28
点击:99
upcoming date New DATA CIRSE 2021...
[TARE vs TACE]
结直肠癌肝转移:放射性栓塞与化疗性栓塞的比较
日期:2022-03-02 16:43:38
点击:99
欧洲医学肿瘤学会(ESMO)和(美国)国家综合癌症网络指南(NCCN)最近将介入治疗纳入了治疗结肠直肠癌(CRC)少转移性疾病(OMD)的标准治疗方法 ESMO指南 所谓少转移性疾病或者称寡转移性疾病(oligometastatic disease,OMD)是指数量和分布有限的远处转移性疾病状...
[影像学随访]
肝癌TACE的随访
日期:2022-02-23 00:42:49
点击:99
TACE术后病人的随访包括临床和影像 BCLC staging and treatment strategy, 2012 Forner, et al. Lancet. 2012 Mar 31;379(9822):1245-55. 为什么说TACE是中期肝癌的标准治疗 *P values refer to cumulative meta-analysis of five and six studies, respecti ...
[HAIC技术]
HAIC技术
日期:2022-02-13 22:13:20
点击:99
尽管标准化的HAIC技术是评估HAIC安全性和疗效的重要因素,但HAIC技术的异质性仍然是评价这一技术的争议之一。 许多HAI化疗技术可以通过放置一个输液港-导管系统来进行。 在过去,输液导管是通过剖腹手术植入的,但患者暴露于与剖腹手术和全身麻醉相关的风险。...
[HAIC单治疗]
HAIC
日期:2022-02-10 00:59:23
点击:99
简介 Hepatic artery infusion chemotherapy (HAIC) is a treatment modality for advanced hepatocellular carcinoma (HCC). 肝动脉输注化疗(HAIC)是治疗晚期肝癌(HCC)的一种治疗方式。 HAIC entails infusing chemotherapeutic agents directly into hepat...
[HAIC联合治疗]
基于HAIC的联合治疗
日期:2022-02-10 00:39:13
点击:99
The following characteristics of HAIC render it a suitable candidate for combination with other antineoplastic agents for advanced HCC: it is associated with fewer systemic adverse events compared with intravenous chemotherapy, and its cyt...
[术前准备]
术前准备
日期:2021-12-31 13:54:16
点击:99
参与此项治疗的介入医生、外科医生和肿瘤内科医生应详知HAIC(经动脉灌注化疗)方法,原理,相关并发症和病人管理。 Work-upPreoperative imaging included cross-sectional imaging with computed tomography (CT) and/or magnetic resonance imaging (MRI)...
[缺乏进行试验的行业激励措施]
HAIC研究潜在障碍:缺乏行业激励
日期:2021-12-28 21:43:21
点击:99
Lack of Industry Incentive for Conducting Trials 开展试验缺乏行业激励 The patents for the main chemotherapeutic agents used in HAIC, including cisplatin, oxaliplatin, 5-FU, and epirubicin, have expired, thus weakening the motivation for th...
[缺乏技术标准]
HAIC研究潜在障碍:技术标准化不足
日期:2021-12-28 13:45:34
点击:99
Insufficient Technical Standardization Techniques and protocols for HAIC have yet to be standardized. HAIC的技术和方案尚未标准化。 The efficacy and safety of HAIC depend substantially on the quality of vascular redistribution. HAIC的有效性...
[重复导管 vs 动脉港]
HAIC研究潜在障碍:重复导管术 vs 药盒置入
日期:2021-12-28 13:34:36
点击:99
Two different percutaneous arterial access approaches have been used for HAIC: the first approach entails the use of implantable port-catheter systems, and the second approach involves repeated hepatic artery catheterization. 两种不同的经...
经导管动脉化疗性栓塞(Transcatheter arterial chemotherapy,TACE)是一种治疗肝脏...
适应症 当患者无法 正常 通过经口途径满足饮食热量摄入时:95%的病例 头颈部肿瘤、围...
男,69岁 - 代谢功能障碍肝硬化合并酒精性肝病(MetALD) - II型糖尿病,高血压 - Chi...
局部治疗联合免疫治疗原理...
单纯肝动脉栓塞的背景 Bland embolisation: Background 肝癌单纯栓塞(Bland emboliza...
肝细胞癌(HCC)是癌症死亡的重要原因,被认为是世界上第三大致命疾...